TCL Archive In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says February 12, 1999
TCL Archive Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000 July 1, 2011
TCL Archive Arzerra Maintenance Therapy Extends PFS In Phase III Trial, Compared to Observation August 29, 2014